{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:43Z","timestamp":1787070883593,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the role of BCL6B methylation in the progression of early-stage hepatocellular carcinoma (HCC) after thermal ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This is a retrospective study and written informed consent was obtained from all patients or their legal guardians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>Between October 2008 and December 2013, 73 patients with early-stage HCC within the Milan criteria, who received thermal ablation, were recruited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Based on methylation-specific polymerase chain reaction, the relationship between BCL6B methylation and patient characteristics and prognosis was analyzed using univariate, multivariate, and Kaplan\u2013Meier analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The median follow-up period was 56 (8\u2013110) months. For the BCL6B unmethylated group, the 1-, 3- and 5-year metastasis and overall survival (OS) rates after thermal ablation were 10.0%, 10.0%, and 40.0% and 100%, 100% and 90.0%, respectively. The 1-, 3-, and 5-year metastasis and OS rates of the methylated group were 23.8%, 66.7% and 88.9% and 66.2%, 71.4% and 41.3%, respectively. Levels of absolute count lymphocyte, serum cholinesterase and albumin in the BCL6B unmethylated group were higher than those in the methylated group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.020, 0.000, and 0.009, respectively). Kaplan\u2013Meier analysis revealed that BCL6B methylation was related to metastasis and poor prognosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001 and 0.018, respectively). Univariate analysis revealed that BCL6B methylation was a risk factor for metastasis and poor prognosis (odds ratio [OR]: 5.663; 95% confidence interval [CI], 1.745\u201318.375,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004 and OR: 3.734; 95% CI, 1.151\u201312.110,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.028, respectively). Multivariate analysis revealed that BCL6B methylation was an independent risk factor for metastasis (OR: 3.736; 95% CI, 1.000\u201313.963,P = 0.05) and not for prognosis (OR: 2.780; 95% CI, 0.835\u20139.250,P = 0.096).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>BCL6B methylation could be a valuable prognostic factor for metastasis and poor prognosis in early-stage HCC after thermal ablation, which is an independent risk factor for metastasis. Our findings provide insights for combining ablation and epigenetic therapy for patients with HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1504_20","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T04:17:46Z","timestamp":1625804266000},"page":"644-651","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation"],"prefix":"10.4103","volume":"17","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20241021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-6-20241021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R3-6-20241021","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/hep.26703","article-title":"Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan","volume":"59","author":"Yeh","year":"2014","journal-title":"Hepatology"},{"key":"R4-6-20241021","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"Altekruse","year":"2009","journal-title":"J Clin Oncol"},{"key":"R5-6-20241021","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"R6-6-20241021","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/gutjnl-2011-300975","article-title":"Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China","volume":"61","author":"Liang","year":"2012","journal-title":"Gut"},{"key":"R7-6-20241021","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1046\/j.1440-1746.1999.01873.x","article-title":"Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma","volume":"14","author":"Johnson","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-6-20241021","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1038\/sj.onc.1206774","article-title":"Cancer epigenetics","volume":"22","author":"Momparler","year":"2003","journal-title":"Oncogene"},{"key":"R9-6-20241021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1478-3231.2007.01637.x","article-title":"Molecular pathogenesis of hepatocellular carcinoma","volume":"28","author":"Wong","year":"2008","journal-title":"Liver Int"},{"key":"R10-6-20241021","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"R11-6-20241021","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/gutjnl-2015-311292","article-title":"Epigenetics in liver disease: From biology to therapeutics","volume":"65","author":"Hardy","year":"2016","journal-title":"Gut"},{"key":"R12-6-20241021","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: A new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"R13-6-20241021","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000015617","article-title":"Assignment of B-cell lymphoma 6, member B (zinc finger protein) gene (BCL6B) to human chromosome 17p13.1 by in situ hybridization","volume":"89","author":"Fitzgibbon","year":"2000","journal-title":"Cytogenet Cell Genet"},{"key":"R14-6-20241021","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gutjnl-2011-300411","article-title":"Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival","volume":"61","author":"Xu","year":"2012","journal-title":"Gut"},{"key":"R15-6-20241021","first-page":"651","article-title":"Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling","volume":"5","author":"Hu","year":"2015","journal-title":"Am J Cancer Res"},{"key":"R16-6-20241021","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.18632\/oncotarget.3413","article-title":"Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"R17-6-20241021","doi-asserted-by":"crossref","first-page":"20252","DOI":"10.18632\/oncotarget.3857","article-title":"BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"R18-6-20241021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canlet.2014.08.025","article-title":"B cell CLL\/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice","volume":"355","author":"Wang","year":"2014","journal-title":"Cancer Lett"},{"key":"R19-6-20241021","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.3748\/wjg.v19.i33.5430","article-title":"Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy","volume":"19","author":"Liang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R20-6-20241021","first-page":"867","article-title":"Immunotherapy for hepatocellular carcinoma following thermal ablation","volume":"19","author":"Li","year":"2014","journal-title":"J BUON"},{"key":"R21-6-20241021","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/gutjnl-2015-310258","article-title":"Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation","volume":"64","author":"Yu","year":"2015","journal-title":"Gut"},{"key":"R22-6-20241021","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands","volume":"93","author":"Herman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-6-20241021","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1158\/1078-0432.CCR-05-2858","article-title":"Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus","volume":"12","author":"Guo","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R24-6-20241021","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/gutjnl-2016-312629","article-title":"Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: A phase III randomised controlled trial","volume":"66","author":"Yu","year":"2017","journal-title":"Gut"},{"key":"R25-6-20241021","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat Biotechnol"},{"key":"R26-6-20241021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"R27-6-20241021","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"Feinberg","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R28-6-20241021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"R29-6-20241021","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nmat4997","article-title":"Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat Mater"},{"key":"R30-6-20241021","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4103\/0366-6999.176982","article-title":"Postoperative low absolute lymphocyte counts may predict poor outcomes of hepatocellular carcinoma after liver resection","volume":"129","author":"Wang","year":"2016","journal-title":"Chin Med J (Engl"},{"key":"R31-6-20241021","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/intimm\/dxh144","article-title":"BAZF is required for activation of naive CD4 T cells by TCR triggering","volume":"16","author":"Takamori","year":"2004","journal-title":"Int Immunol"},{"key":"R32-6-20241021","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1073\/pnas.0501585102","article-title":"BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+T lymphocytes","volume":"102","author":"Manders","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-6-20241021","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12964-019-0387-6","article-title":"Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice","volume":"17","author":"Cai","year":"2019","journal-title":"Cell Commun Signal"},{"key":"R34-6-20241021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/jcrt.JCRT_1021_19","article-title":"US-guided percutanous microwave ablation for early-stage hepatocellular carcinoma in elderly patients is as effective as in younger patients: A 10-year experience","volume":"16","author":"Wang","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"R35-6-20241021","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.crad.2016.07.002","article-title":"Thermal ablation for hepatocellular carcinoma: A large-scale analysis of long-term outcome and prognostic factors","volume":"71","author":"Ding","year":"2016","journal-title":"Clin Radiol"},{"key":"R36-6-20241021","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrclinonc.2013.42","article-title":"The future of epigenetic therapy in solid tumours \u2013 Lessons from the past","volume":"10","author":"Azad","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R37-6-20241021","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/annonc\/mdy050","article-title":"Epigenetic modifiers as new immunomodulatory therapies in solid tumours","volume":"29","author":"Aspeslagh","year":"2018","journal-title":"Ann Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1504_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:13Z","timestamp":1787067493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1504_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1504_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}